HYPERCHOLESTEROLEMIA Overview
Upcoming Projects (HYPERCHOLESTEROLEMIA)
-
Don’t see a project related to the keyword you care about? Create your own!
Executed Projects (HYPERCHOLESTEROLEMIA)
-
A Third View: Discussing the recent data from the Phase III V-MONO clinical trial of Leqvio in patients at risk of developing atherosclerotic cardiovascular disease
Ticker: NVS
Executed On: Sep 26, 2024 at 09:30 AM EDT -
A Second View: Discussing the recent data from the Phase III V-MONO clinical trial of Leqvio in patients at risk of developing atherosclerotic cardiovascular disease
Ticker: NVS
Executed On: Sep 12, 2024 at 10:00 AM EDT -
Discussing the recent data from the Phase III V-MONO clinical trial of Leqvio in patients at risk of developing atherosclerotic cardiovascular disease
Ticker: NVS
Executed On: Sep 05, 2024 at 11:00 AM EDT -
A Third Look: Investigating the Phase 3 LIBerate clinical trial of Lerodalcibep for the treatment of high cholesterol.
Ticker: LIB THERAPEUTICS
Executed On: Jul 12, 2024 at 12:00 PM EDT -
A Second Look: Investigating the Phase 3 LIBerate clinical trial of Lerodalcibep for the treatment of high cholesterol.
Ticker: LIB THERAPEUTICS
Executed On: Jun 10, 2024 at 10:00 AM EDT -
Investigating the Phase 3 LIBerate clinical trial of Lerodalcibep for the treatment of high cholesterol.
Ticker: LIB THERAPEUTICS
Executed On: Apr 25, 2024 at 05:30 PM EDT -
A Third Look: Discussing the recent interim results from the heart-1 clinical trial of VERVE-101 in patients with heterozygous familial hypercholesterolemia.
Tickers: VERV, NVS
Executed On: Nov 22, 2023 at 05:05 PM EST -
A Second Look: Discussing the recent interim results from the heart-1 clinical trial of VERVE-101 in patients with heterozygous familial hypercholesterolemia.
Tickers: VERV, NVS
Executed On: Nov 20, 2023 at 11:00 AM EST -
Discussing the recent interim results from the heart-1 clinical trial of VERVE-101 in patients with heterozygous familial hypercholesterolemia.
Tickers: VERV, NVS
Executed On: Nov 17, 2023 at 12:35 PM EST -
A third look: Discussing the phase 3 CREDIT clinical trials of Sintbilo (Tafolecimab Injection) in patients with primary hypercholesterolemia and mixed dyslipidemia.
Ticker: 1801.XHKG
Executed On: Sep 07, 2023 at 06:00 PM EDT -
A second look: Discussing the phase 3 CREDIT clinical trials of Sintbilo (Tafolecimab Injection) in patients with primary hypercholesterolemia and mixed dyslipidemia.
Ticker: 1801.XHKG
Executed On: Aug 31, 2023 at 12:30 PM EDT -
Discussing the phase 3 CREDIT clinical trials of Sintbilo (Tafolecimab Injection) in patients with primary hypercholesterolemia and mixed dyslipidemia.
Ticker: 1801.XHKG
Executed On: Aug 25, 2023 at 05:00 PM EDT -
A third look: Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 14, 2023 at 07:00 PM EDT -
A second look: Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 14, 2023 at 06:00 PM EDT -
Digging in to the Phase 2b data presented at the AAC Conference for Merck's oral PCSK9 inhibitor, MK-0616, in patients with hypercholesterolemia
Ticker: MRK
Executed On: Mar 13, 2023 at 04:00 PM EDT -
Discussing Leqvio (Inclisiran) in treating high LDL cholesterol associated with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) - 3rd look
Ticker: NVS
Executed On: Feb 25, 2022 at 01:00 PM EST -
Discussing Leqvio (Inclisiran) in treating high LDL cholesterol associated with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) - 2nd look
Ticker: NVS
Executed On: Feb 17, 2022 at 06:00 PM EST -
Discussing Leqvio (Inclisiran) in treating high LDL cholesterol assocaited with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH)
Ticker: NVS
Executed On: Feb 11, 2022 at 04:30 PM EST
Upcoming & Overdue Catalysts (HYPERCHOLESTEROLEMIA)
-
Don’t see a catalyst related to the keyword you care about? Create your own!
Strategic Initiatives (HYPERCHOLESTEROLEMIA)
-
Don’t see a strategic initiative related to the keyword you care about? Create your own!
